top of page

Latest News

Jan 20, 2023

Neuro-Oncology Advances Publishes About Neosoma's Technology

Neosoma HGG's (NS-HGlio) Technology and Development was Recently Published in Neuro-Oncology Advances

Neuro-Oncology Advances Publishes About Neosoma's Technology

Dec 9, 2022

Neosoma Participates in Big Data Federated Learning Study

UPenn-led study brought together almost 6,500 brain cancer MRIs from 71 sites on 6 continents to study the benefits of federated-learning-based AI on glioblastoma segmentation.

Neosoma Participates in Big Data Federated Learning Study

Nov 17, 2022

AI-Powered Neuro-Oncology Clinical Trials

Neosoma's strategic partnership with Calyx enables faster, more precise tumor assessment in brain cancer clinical trials.

AI-Powered Neuro-Oncology Clinical Trials

Nov 7, 2022

Neosoma Announces Partnership with Nuance Communications

Neosoma Announced Today its AI Solutions Connect to the Nuance Precision Imaging Network

Neosoma Announces Partnership with Nuance Communications

Sep 29, 2022

Neosoma Announces FDA 510(k) Clearance for Neosoma HGG

Neosoma Announced Today It Has Received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Its First AI-Based Neuro-Oncology Software, Neosoma HGG

Neosoma Announces FDA 510(k) Clearance for Neosoma HGG
bottom of page